The cellular characterization of SARS-CoV-2 spike protein in virus-infected cells using the receptor binding domain binding specific human monoclonal antibodies by Chan, Conrad En-Zuo, Ng, Ching-Ging, Lim, Angeline Pei-Chew, Seah, Shirley Lay-Kheng, Chye, De-Hoe, Wong, Steven Ka-Khuen, Lim, Jie-Hui, Lim, Vanessa Zi-Yun, Lai, Soak-Kuan, Wong, Pui-San, Leong, Kok-Mun, Liu, Yi-Chun, Sugrue, Richard J., Tan, Boon Huan

Subjects: Get full text

Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2 by Zsofia Hevesi, Daniela Anna Gerges, Sebastian Kapps, Raimundo Freire, Sophie Schmidt, Daniela D. Pollak, Klaus Schmetterer, Tobias Frey, Rita Lang, Wolfgang Winnicki, Alice Schmidt, Tibor Harkany, Ludwig Wagner

Subjects: “…receptor-binding domain…”
Get full text

Impact of glycosylation and length of RBD of SARS-CoV-2 S protein on the immunogenicity of RBD protein vaccines by ZHANG Ting, WANG Zhi-rong, XU Xue-mei

Subjects: “…sars-cov-2|receptor binding domain|glycosylation…”
Get full text

The Occluded Epitope Residing in Spike Receptor-Binding Motif Is Essential for Cross-Neutralization of SARS-CoV-2 Delta Variant by Weeraya Thongkum, Kanyarat Thongheang, Chatchai Tayapiwatana

Subjects: Get full text

Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike by Yajuan Li, Peiyi Zheng, Tingting Liu, Cuixiao Shi, Bo Wang, Yuanhong Xu, Tengchuan Jin

Subjects: Get full text

Structure-based design of oligomeric receptor-binding domain (RBD) recombinant proteins as potent vaccine candidates against SARS-CoV-2 by Ting Zhang, Ningchen Zheng, Zhirong Wang, Xuemei Xu

Subjects: Get full text

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain by Ping-Han Huang, Hsiao-Han Tsai, Bo-Hung Liao, Yi-Ling Lin, Jia-Tsrong Jan, Mi-Hua Tao, Yu-Chi Chou, Che-Ming Jack Hu, Hui-Wen Chen

Subjects: Get full text

Nanobody peptide conjugate: a novel CD163 based broad neutralizing strategy against porcine reproductive and respiratory syndrome virus by Haotian Yang, Meiqi Sun, He Qiu, Huiling Xu, Zhuofan Deng, Han Gu, Nan Wang, Liuyang Du, Fushan Shi, Jiyong Zhou, Fang He

Subjects: Get full text

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2 by Juan Shi, Yu Zhao, Min Peng, Suyue Zhu, Yandan Wu, Ruixue Ji, Chuanlai Shen

Subjects: Get full text

Comparative Analysis of Nucleocapsid Antibody Levels, Neutralizing Antibodies, and Spike Receptor-binding Domain in Severe Acute Respiratory Syndrome Coronavirus-2 Patients by Rinta Prasetiyanti, Munawaroh Fitriah, Yufi Aulia Azmi, Kevin Muliawan Soetanto, Marvin Castillo

Subjects: Get full text

Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Em... by Yoshitomo Morinaga, Hideki Tani, Yasushi Terasaki, Satoshi Nomura, Hitoshi Kawasuji, Takahisa Shimada, Emiko Igarashi, Yumiko Saga, Yoshihiro Yoshida, Rei Yasukochi, Makito Kaneda, Yushi Murai, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Kentaro Nagaoka, Chikako Ono, Yoshiharu Matsuura, Takashi Fujimura, Yoichi Ishida, Kazunori Oishi, Yoshihiro Yamamoto

Subjects: Get full text

Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug by Gan, Hanjie Jonathan, Harikishore, Amaravadhi, Lee, Jihye, Jeon, Sangeun, Rajan, Sreekanth, Chen, Ming Wei, Neo, Jun Long, Kim, Seungtaek, Yoon, Ho Sup

Subjects: Get full text

Immunogenicity and Protection from Receptor-Binding Domains of Toxins as Potential Vaccine Candidates for <i>Clostridium difficile</i> by Deyan Luo, Xuechao Liu, Li Xing, Yakun Sun, Jie Huang, Liangyan Zhang, Jiajia Li, Hui Wang

Subjects: Get full text

An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants by Trina Ekawati Tallei, Trina Ekawati Tallei, Fatimawali, Fatimawali, Afriza Yelnetty, Rinaldi Idroes, Diah Kusumawaty, Talha Bin Emran, Talha Zahid Yesiloglu, Wolfgang Sippl, Shafi Mahmud, Taha Alqahtani, Ali M. Alqahtani, Saeed Asiri, Mohammed Rahmatullah, Rownak Jahan, Md. Arif Khan, Ismail Celik

Subjects: Get full text

E. coli production of a multi-disulfide bonded SARS-CoV-2 Omicron BA.5 RBD exhibiting native-like biochemical and biophysical properties by Rawiwan Wongnak, Subbaian Brindha, Takahiro Yoshizue, Sawaros Onchaiya, Kenji Mizutani, Yutaka Kuroda

Subjects: “…receptor binding domain…”
Get full text

Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis by Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi

Subjects: Get full text

An Insight Based on Computational Analysis of the Interaction between the Receptor-Binding Domain of the Omicron Variants and Human Angiotensin-Converting Enzyme 2 by Ismail Celik, Magda H. Abdellattif, Trina Ekawati Tallei

Subjects: Get full text

In Silico Comparison of Separate or Combinatorial Effects of Po-tential Inhibitors of the SARS-CoV-2 Binding Site of ACE2 by Mostafa Shakhsi-Niaei, Ehsan Heidari Soureshjani, Ali Kazemi Babaheydari

Subjects: Get full text

Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Develop... by Janet K. Yamamoto, Lekshmi K. Edison, Dawne K. Rowe-Haas, Tomomi Takano, Chen Gilor, Chiquitha D. Crews, Apichai Tuanyok, Ananta P. Arukha, Sayaka Shiomitsu, Heather D. S. Walden, Tsutomu Hohdatsu, Stephen M. Tompkins, John G. Morris Jr., Bikash Sahay, Subhashinie Kariyawasam

Subjects: Get full text

Severe acute respiratory syndrome coronavirus 2 variants–Possibility of universal vaccine design: A review by Eunhye Yoon, Dahyun Kim, Hyeeun Jeon, Yejin Kwon, Yejin Jang, Sulhee Kim, Kwang Yeon Hwang

Subjects: Get full text